单倍率不足
遗传学
生物
先证者
心脏发育
心脏病
医学
基因
突变
内科学
表型
胚胎干细胞
作者
Ana S.A. Cohen,Christopher Simotas,Bryn D. Webb,Huanzhi Shi,Wahab Khan,Lisa Edelmann,Stuart A. Scott,Ram J. Singh
摘要
Abstract Congenital heart defects (CHDs) are caused by a disruption in heart morphogenesis, which is dependent, in part, on a network of transcription factors (TFs) that regulate myocardial development. Heterozygous sequence variants in the basic helix–loop–helix TF gene heart and neural crest derivatives expressed 2 ( HAND2) have been reported among some patients with CHDs; however, HAND2 has not yet been established as a Mendelian disease gene. We report a 31‐month‐old male with unicommissural unicuspid aortic valve, moderate aortic stenosis, and mild pulmonic stenosis. Chromosome analysis revealed a normal 46,XY karyotype, and a CHD sequencing panel was negative for pathogenic variants in NKX2.5 , GATA4 , TBX5 , and CHD7 . However, chromosomal microarray (CMA) testing identified a heterozygous 546.0‐kb deletion on chromosome 4q34.1 (174364195_174910239[GRCh37/hg19]) that included exons 1 and 2 of SCRG1 , HAND2 , and HAND2‐AS1 . Familial CMA testing determined that the deletion was paternally inherited, which supported a likely pathogenic classification as the proband's father had previously undergone surgery for Tetralogy of Fallot. The family history was also notable for a paternal uncle who had previously died from complications related to an unknown heart defect. Taken together, this first report of a HAND2 and HAND2‐AS1 deletion in a family with CHDs strongly supports haploinsufficiency of HAND2 as an autosomal dominant cause of CHD.
科研通智能强力驱动
Strongly Powered by AbleSci AI